Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 227,077,414 papers from all fields of science
Search
Sign In
Create Free Account
Stage III Lung Adenocarcinoma
Known as:
Stage III Adenocarcinoma of Lung
, Stage III Lung Adenocarcinoma AJCC v7
, Stage III Adenocarcinoma of the Lung
Expand
Stage III includes: IIIA (T1a, N2, M0); (T1b, N2, M0); (T2a, N2, M0); (T2b, N2, M0); (T3, N1, M0); (T3, N2, M0); (T4, N0, M0); (T4, N1, M0) and IIIB…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
27 relations
ALK gene
Chest
Chromosome 13q deletion
Coughing
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Targeted Therapy Followed by Cytotoxic Chemotherapy in Preoperative Patients With Locally Advanced Lung Adenocarcinoma
M. Aoki
,
K. Ueda
,
+11 authors
Masami Sato
Anticancer Research
2020
Corpus ID: 218504429
Background: Although oncogene-targeted therapy is a first-line treatment for advanced, unresectable lung adenocarcinoma harboring…
Expand
2018
2018
Use of 18F-FDG PET/CT to predict short-term outcomes early in the course of chemoradiotherapy in stage III adenocarcinoma of the lung.
Xiang-Rong Zhao
,
Yong Zhang
,
Yong-hua Yu
Oncology Letters
2018
Corpus ID: 51876668
The purpose of the present prospective study was to evaluate the use of 18F-fluorodeoxyglucose positron emission tomography…
Expand
2017
2017
Is MPP a good prognostic factor in stage III lung adenocarcinoma with EGFR exon 19 mutation?
Tian Zhang
,
Jing Wang
,
+8 authors
Ping Wang
OncoTarget
2017
Corpus ID: 4756666
Epidermal growth factor receptor (EGFR) is a transmembrane glycoprotein encoded by a gene located in the short arm of chromosome…
Expand
2016
2016
Whole exome sequencing analysis of the neoadjuvant bevacizumab plus pemetrexed and carboplatin for unresectable stage III lung adenocarcinoma: Results of the phase II GASTO 1001 trial.
Si-Yu Wang
,
W. Ou
,
Ning Li
,
Pengfei Xu
,
Xiaoyong Mao
,
Bao‐Xiao Wang
2016
Corpus ID: 80706926
e20045Background: GASTO 1001 is a phase II trial investigating the efficacy and safety of induction bevacizumab plus chemotherapy…
Expand
2015
2015
Phase II trial of neoadjuvant bevacizumab plus pemetrexed and carboplatin in patients with unresectable stage III lung adenocarcinoma (GASTO 1001).
Si-Yu Wang
,
W. Ou
,
+5 authors
Bao‐Xiao Wang
2015
Corpus ID: 196485888
7528 Background: Unresectable stage III non-small cell lung cancer is often treated with concurrent chemoradiotherapy…
Expand
2014
2014
The impact of EGFR mutation on definitive concurrent chemoradiation therapy for inoperable stage III lung adenocarcinoma.
Kosuke Tanaka
,
T. Oguri
,
+5 authors
T. Hida
2014
Corpus ID: 78257224
7558 Background: Concurrent chemoradiation therapy (CRT) is the current standard of care for patients with locally advanced lung…
Expand
2012
2012
Recruitment of Podoplanin Positive Cancer-Associated Fibroblasts in Metastatic Lymph Nodes Predicts Poor Prognosis in Pathological N2 Stage III Lung Adenocarcinoma
S. Neri
,
G. Ishii
,
+5 authors
A. Ochiai
Annals of Surgical Oncology
2012
Corpus ID: 23666794
BackgroundCancer-associated fibroblasts (CAFs) directly communicate with cancer cells and play important roles in cancer…
Expand
2011
2011
Clinical research of pemetrexed/cisplatin concurrent and consolidate chemotherapy cambined with conformal or intensity-modulated radiotherapy for patients with unresectable stage III lung…
Li Gao-feng
2011
Corpus ID: 76557845
Objective To evaluate the efficacy and safety of pemetrexed and cisplatin concurrent and consolidate chemotherapy combined with…
Expand
2011
2011
Abstract 3165: Profiling of circulating tumor-associated autoantibodies for lung adenocarcinoma detection
Yibing Yao
,
Zhi-cheng Wu
,
+5 authors
Qinghua Zhou
2011
Corpus ID: 72563479
Proceedings: AACR 102nd Annual Meeting 2011‐‐ Apr 2‐6, 2011; Orlando, FL Purpose: To identify a panel of tumor associated…
Expand
1995
1995
Botulinum toxin for suspected pseudoachalasia.
R. Vallera
,
S. Brazer
American Journal of Gastroenterology
1995
Corpus ID: 35174626
We describe a 74-yr-old man with stage III adenocarcinoma of the lung who presented with suspected malignancy-induced secondary…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE